Regeneron Pharmaceuticals (REGN)
$1,063.60
0.00 (0.00%)
REGN Stock Quote Delayed 30 Minutes
Stock Market Today: Coronavirus Sparks 1,000-Point Dow Fall
At one point, the Dow Jones slid 1,000 and the Nasdaq was down more than 4% thanks to the coronavirus. Here's the stock market today.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
97.62B
PE Ratio
31.41
EPS
33.86
Volume (Avg. Vol.)
7,903
Day's Range
-
52-Week Range
$721.51 - $1,106.16
Dividend & Yield
N/A (N/A)
REGN Stock Predictions, Articles, and Regeneron Pharmaceuticals News
3 Big Stock Charts for Thursday: Kraft Heinz, Wabtec, and Regeneron Pharmaceuticals
Thursday's big stock charts detail the hopes for 3 stocks trying to recover from multi-year lows.
Regeneron Pharmaceuticals Earnings: REGN Stock Rockets 7% on Q3 Beat
Regeneron Pharmaceuticals (REGN) earnings for the biotechnology company's third quarter of 2019 have REGN stock soaring on Tuesday.
Why This Just Might Be the Biggest Week for CARA Stock
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
3 Biotech Stocks That Show The Good, The Bad and the Ugly Side of This Sector
When rumors start buzzing that the government may be about to intervene, then biotech stocks often get slammed...some fairly, and some not (as we’ll see).
Nasdaq Today: Biotech Wrecked; Buy Microsoft?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
This Medical Device Company is Outperforming the Rest of the Sector
This morning, I am recommending a bullish trade on Repligen Corporation (NASDAQ:RGEN), the bioprocessing company.
Regeneron Pharmaceuticals Earnings: REGN Stock Drops on Q1 Miss
Regeneron Pharmaceuticals earnings for the first quarter of 2019 have REGN stock falling on Tuesday due to poor results for the period.
This Is Why You Shouldn’t Count Regeneron Stock Out
When drug companies fall out of favor, as now, I look first to companies with a method for drug discovery like Regeneron stock.
Market Leadership’s Odd Couple: Wingstop and Regeneron
It might seem like an odd pairing, but WING and REGN stock have similar leadership qualities off and on the price chart.
